William E. Solander

Solander William
Bill Solander is a first-chair trial lawyer who represents pharmaceutical and other clients in high-stakes patent disputes, with particularly deep experience in Abbreviated New Drug Application (ANDA) litigation. He has secured victories in a wide variety of forums, including federal district and appellate courts, the Patent Trial and Appeal Board (PTAB), and civil arbitrations. His experience includes prescription antiarrhythmic drugs, protein synthesis, new battery technologies, and prescription sleep aids.

Bill has developed significant knowledge of IP laws and civil justice systems outside the United States, and frequently counsels clients who seek strategic advice concerning business and legal activities outside the U.S. He has been on trial teams in Australia, Canada, Germany, Israel, and the United Kingdom, among other countries.


Representative Matters

  • Represented Sanofi Genzyme against several generics on patents relating to Cerdelga® for the treatment of Gaucher disease (D. Del.)
  • Represented Grünenthal against Antecip in contested proceedings in the USPTO relating to the use of bisphosphonates for the treatment of chronic pain (PTAB)
  • Represented Sanofi against several generics on patents relating to Jevtana® for the treatment of prostate cancer (D.N.J., PTAB, Fed. Cir.)
  • Represented Sanofi against several generics on patents relating to Multaq® for the treatment of atrial fibrillation (D. Del., Fed. Cir.)
  • Represented Hoechst GmbH against Genentech, Inc., in an arbitration before the ICC International Court of Arbitration concerning royalties due under a terminated license involving eukaryotic protein expression technologies, and Sanofi-Aventis Deutschland GmbH against Genentech and Biogen-IDEC on patents covering those technologies
  • Represented LEO Pharma against Tolmar Inc. and Perrigo Inc. on patents related to Taclonex, a topical anti-psoriatic medication
  • Represented Sepracor Pharmaceuticals against Sandoz Inc., et al. on patents related to Clarinex®, an allergy medication
  • Represented Sanofi against Sandoz Inc., et al. on a patent related to Ambien CR®, a sleep aid
  • Represented Sanofi in Sanofi v. Sandoz Inc., et al. on a patent related to Eloxatin®, a platinum-containing anti-cancer drug
  • Represented Novartis Pharmaceuticals Corporation against Mylan Pharmaceuticals on a patent related to Femara®, an aromatase inhibitor
  • Represented Bristol-Myers Squibb against Repligen in an inventorship lawsuit related to Bristol-Myers Squibb’s protein-fusion drug Orencia®
  • Represented Sanofi and Bristol-Myers Squibb against Apotex, et al. on patents covering Plavix®, a leading anti-thrombotic agent
  • Represented Sanofi and Bristol-Myers Squibb against Sun Pharmaceuticals on a patent related to the crystalline form of the active ingredient in Plavix®
  • Represented Novartis Pharmaceuticals Corporation against Dr. Reddy’s Laboratories Ltd. on patents covering Lamisil®, an anti-fungal medicine
  • Represented Bristol-Myers Squibb against Rhône-Poulenc Rorer, Inc. et al. on patents related to semi-synthetic process technology for making Taxol®
  • Represented Yamanouchi against Danbury Pharmacal on a patent related to Pepcid®, an anti-ulcer drug

Representative Clients

  • Astellas Pharma
  • Bristol-Myers Squibb 
  • Gilead
  • Hoechst GmbH
  • LEO Pharma
  • Novartis
  • Sanofi
  • Sunovion Pharmaceuticals
  • Warner Chilcott




  • J.D. Chicago Kent College of Law 1995
  • B.S. Chemistry California Polytechnic State University 1991

Bar Admissions

  • New York

Court Admissions

  • U.S. Court of Appeals for the Federal Circuit
  • U.S. District Court for the Southern District of New York

Professional Memberships and Activities

  • Speaks and writes frequently on litigation strategy, polymorph patents, and Hatch-Waxman litigation


Mentored by the renowned patent litigator Robert Baechtold until his retirement, Bill has earned his own “fantastic reputation” as “a truly excellent patent litigator” (Chambers USA).

  • Named in Best Lawyers in America, 2012 - 2021
  • Ranked by Benchmark Litigation as a "Local Litigation Star," 2020
  • Recognized in Chambers USA, 2008 - 2018
  • Recognized in Managing Intellectual Property, IP Star, 2013 - 2020
  • Included in IAM Patent 1000, 2012 - 2018
  • Listed in Super Lawyers: New York Metro Edition, 2013 - 2019
  • Recognized by LMG Life Sciences, 2016 - 2019
  • Recognized in Legal 500 for Patent Litigation – Full Coverage, 2014, 2016 - 2018
  • Recognized in IAM Life Sciences 250, 2010, 2011
  • Listed in Legal Media Group Guide to the World’s Leading Patent Law Practitioners, 2007